LexDanaLexDanabeta
New SessionDrug SearchOfficial RankingsInsights
© LexDana · beta
LexDanaLexDanabeta
New SessionDrug SearchOfficial RankingsInsights
LexDanaLexDanabeta

Insights

Analysis of patent litigation, PTAB practice, prosecution and pharma IP, written on the data behind LexDana.

AllCopyright & Trade Secrets59Federal Circuit877ITC / Section 33788Patent Litigation216Patent Prosecution126Pharma & ANDA62PTAB686Supreme Court61Trademark158USPTO Policy78Unsorted257

Tagged u.s. competitiveness · clear

USPTO Policy

Experts Void From U S Patent Train Wreck Is Being Filled by China S Patent System

In a few short years China’s patent system has gone from an IP rights wannabe to one of the most responsive and patent-friendly systems in the world. Leading U.S. IP experts say that underlying this rapid evolution is a desire for China to become a…

January 30, 2017·USPTO Policy·5 min read
Data: FDA Orange & Purple Books · prosecution & litigation metadata · read-only.